Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

Biological specimen collection: Collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.

Study summary

The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the Oncology Research Information Exchange Network (ORIEN) Consortium of academic medical centers, community hospital systems, and other health care providers. To bring new translational research to the community, the ORIEN consortium has initiated the ORIEN Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.

Eligibility

Primary outcome measure(s)

• Amount of clinical patient demographic data collected for a repository linked to clinical data for long-term research use. — up to 20 years
  Establish a longitudinal clinical data repository that will contain information about patient demographics collected via surveys and questionnaires.
• Amount of clinical patient medical treatment and outcome data collected via medical histories for long-term research use — up to 20 years
  Establish a longitudinal clinical data repository that will contain information about medical treatments and patient outcomes collected via medical chart review and patient medical histories.
• Number of biospecimens collected for a tissue repository linked to clinical data for long-term research use — up to 20 years
  Establish a longitudinal tissue repository that will contain tissues (blood, tumor tissue) and other biological samples and associated clinical data collected from consenting patients.

Trial sites (1)

More New Mexico Cancer Research Alliance trials in Mexico

Other trials for the same condition